Use of Cangrelor and Platelet Reactivity Unit Monitoring in Patients With Acute Ischemic Stroke (SCCM 2026) - Mar 17, 2026 - Pres time: Mar 23, 2026; 02:30 PM - 03:30 PM; Location: Connections Central - RST 06; "Cangrelor may be a safe alternative antiplatelet agent in patients who could not receive oral P2Y12 inhibitors in acute ischemic stroke. PRU assay monitoring could be considered."
Clinical • Cardiovascular • Ischemic stroke
|
|
Angela Castro, PharmD (she/her/hers); Michael Jennison, PharmD; William Cang, BCCCP, PharmD; Yue Wang, PharmD, BCCCP, BCPS
|